OQROGet OQRO Pro
Insider trade

Rapport Therapeutics (RAPP)Chief Scientific Officer sold ~$94K

David Bredt, Chief Scientific Officer at Rapport Therapeutics, sold ~$94K of Rapport Therapeutics shares.

~$94K
Approx. value · 8,500 sh @ $11.00
444K
Holds after · shares reported
Traded
Jun 16, 2025
Filed
Jun 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 15, 2025InsiderOfficer sold ~$81K of RAPP shares in the open market
  2. Jun 16, 2025 · this disclosureInsiderOfficer sold ~$94K of RAPP shares in the open market

What came next

  1. Jul 15, 2025InsiderOfficer sold ~$119K of RAPP shares in the open market
  2. Aug 15, 2025Insider · 1 personInsiders: 2 sales (~$127K)
  3. Sep 8, 2025InsiderOfficer sold ~$192K of RAPP shares in the open market
  4. Sep 9, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  5. Sep 11, 2025InsiderDirector purchased ~$79K of RAPP shares in the open market
  6. Sep 12, 2025Insider · 2 peopleInsiders: 3 purchases (~$1.5M)
  7. Sep 15, 2025Insider · 1 personInsiders: 2 sales (~$206K)
  8. Sep 17, 2025Insider · 1 personInsiders: 4 sales (~$2.0M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rapport Therapeutics

For Rapport Therapeutics, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RAPP page.

Other recent filings by David Bredt, Chief Scientific Officer

The full history of David Bredt, Chief Scientific Officer is on the profile page.

How this filing works

Other disclosures at Rapport Therapeutics

Everything OQRO holds on this company is on its RAPP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data